Phase II Study of Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
Latest Information Update: 06 Mar 2025
At a glance
- Drugs Telaglenastat (Primary) ; Cisplatin
- Indications Adenocarcinoma; Adenosquamous carcinoma; Carcinoma; Cervical cancer; Squamous cell cancer
- Focus Therapeutic Use
Most Recent Events
- 26 Feb 2025 Planned End Date changed from 7 Apr 2031 to 7 Aug 2031.
- 26 Feb 2025 Planned primary completion date changed from 7 Apr 2031 to 7 Aug 2031.
- 26 Feb 2025 Planned initiation date changed from 31 Jan 2025 to 31 May 2025.